On January 26, 2016, a motion for authority to pay claims of employees was filed in the bankruptcy case of Nuo Therapeutics, Inc. (f/k/a Cytomedix, Inc.) and its affiliates.
The filing was assigned docket number 15 and is described on the court’s official docket as follows:
Motion to Pay Employee Wages // Motion Pursuant to Sections 105, 363, 507, 1107, and 1108 of the Bankruptcy Code for Entry of an Order (I) Authorizing Debtor to Pay Prepetition Wages, Salaries, and Benefits; (II) Authorizing Debtor to Continue Employee Benefit Programs in the Ordinary Course of Business; and (III) Directing All Banks to Honor Prepetition Checks for Payment of Prepetition Wage, Salary, and Benefit Obligations Filed By Nuo Therapeutics, Inc. (Skomorucha Owens, Karen) (Entered: 01/26/2016)
Nuo Therapeutics, Inc. (f/k/a Cytomedix, Inc.) filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on January 26, 2016. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 16-10192. The bankruptcy case is currently assigned to United States Bankruptcy Judge Mary Walrath. The law firm of Dentons US LLP is acting as lead bankruptcy counsel to Nuo Therapeutics, Inc. (f/k/a Cytomedix, Inc.) in the bankruptcy case.